Clear overexpression is seen in tumors that have metabolically active oxidative environments, such as hepatocellular carcinoma, renal cell carcinoma or non-small cell lung adenocarcinoma, while in some malignancies, such as multiple myeloma, fewer than half cancerous cells were showing MTH1 overexpression. The gene discussed is NUDT1; the disease is renal cell carcinoma.